Peiqing Liu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Escherichia Coli

Small Cell Lung Cancer

Top Venues

Pharmacological reviews

Cancer research

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hong Wang, Huizi Sun, Jie Huang, Zhenhua Zhang, Guodi Cai, Chaofan Wang, Kai Xiao, Xiao-Feng Xiong, Jian Zhang, Peiqing Liu, Xiaoyun Lu, Weineng Feng, Jun-Jian Wang
Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer. EMBO molecular medicine (2024)
Ziyou Lin, Jingwei Li, Jian Zhang, Weineng Feng, Jiaye Lu, Xiaofan Ma, Wen Ding, Shumin Ouyang, Jin-Jian Lu, Peibin Yue, Guohui Wan, Peiqing Liu, Xiaolei Zhang
Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non-small cell lung cancer. Cancer research (2023)
Jianping Weng, Iqra Ilyas, Peter J Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C Harding, Eno E Ebong, Scott J Cameron, Alastair G Stewart, Jian-Ping Weng
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacological reviews 73 (3) (2021)